UK Kidney Association Clinical Practice Guideline: Sodium-Glucose Co-transporter-2 (SGLT-2) Inhibition in Adults with Kidney Disease 2023 UPDATE.
Acute kidney injury
Chronic kidney disease
Gliflozin
Guideline
Journal
BMC nephrology
ISSN: 1471-2369
Titre abrégé: BMC Nephrol
Pays: England
ID NLM: 100967793
Informations de publication
Date de publication:
25 10 2023
25 10 2023
Historique:
received:
25
04
2023
accepted:
19
09
2023
medline:
27
10
2023
pubmed:
26
10
2023
entrez:
25
10
2023
Statut:
epublish
Résumé
Large placebo-controlled trials have demonstrated kidney and cardiovascular clinical benefits of SGLT-2 inhibitors. Data from the EMPA-KIDNEY and DELIVER trials and associated meta-analyses triggered an update to the UK Kidney Association Clinical Practice Guideline on Sodium-Glucose Co-transporter-2 (SGLT-2) Inhibition in Adults with Kidney Disease. We provide a summary of the full guideline and highlight the rationale for recent updates. The use of SGLT-2 inhibitors in people with specific medical conditions, including type 1 diabetes, kidney transplants, and people admitted to hospital with heart failure is also considered, along with Recommendations for future research and Recommendations for implementation. A full "lay" summary of the guidelines is provided as an appendix to ensure that these guidelines are accessible and understandable to people who are not medical professionals.
Identifiants
pubmed: 37880609
doi: 10.1186/s12882-023-03339-3
pii: 10.1186/s12882-023-03339-3
pmc: PMC10598949
doi:
Substances chimiques
Blood Glucose
0
Hypoglycemic Agents
0
Sodium-Glucose Transporter 2 Inhibitors
0
Types de publication
Journal Article
Practice Guideline
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
310Informations de copyright
© 2023. BioMed Central Ltd., part of Springer Nature.
Références
Lancet. 2022 Nov 19;400(10365):1788-1801
pubmed: 36351458
Diabetes Metab Res Rev. 2007 Jan;23(1):3-13
pubmed: 16960917
N Engl J Med. 1983 Dec 22;309(25):1543-6
pubmed: 6656849
Nat Med. 2022 Mar;28(3):568-574
pubmed: 35228754
N Engl J Med. 2023 Jan 12;388(2):117-127
pubmed: 36331190
JAMA Cardiol. 2023 Jan 1;8(1):56-65
pubmed: 36326604
Clin J Am Soc Nephrol. 2017 May 8;12(5):751-759
pubmed: 28302903
N Engl J Med. 1993 Nov 11;329(20):1456-62
pubmed: 8413456
Diabetes Obes Metab. 2012 Jan;14(1):83-90
pubmed: 21985634
Eur Heart J. 2020 Jul 1;41(25):2379-2392
pubmed: 32221582
ESC Heart Fail. 2022 Aug;9(4):2233-2238
pubmed: 35611683
N Engl J Med. 2017 Dec 14;377(24):2337-2348
pubmed: 28899222
N Engl J Med. 2016 Jul 28;375(4):323-34
pubmed: 27299675
N Engl J Med. 2020 Oct 8;383(15):1436-1446
pubmed: 32970396
Circulation. 2021 Jan 26;143(4):310-321
pubmed: 33095032
Diabetes Obes Metab. 2017 Jan;19(1):142-147
pubmed: 27598833
Lancet Diabetes Endocrinol. 2019 Nov;7(11):845-854
pubmed: 31495651
EClinicalMedicine. 2021 Oct 26;41:101163
pubmed: 34765951
Eur Heart J. 2021 Mar 31;42(13):1216-1227
pubmed: 33792669
N Engl J Med. 2020 Oct 8;383(15):1413-1424
pubmed: 32865377
J Am Coll Cardiol. 2021 Mar 23;77(11):1397-1407
pubmed: 33736821
N Engl J Med. 2001 Sep 20;345(12):851-60
pubmed: 11565517
JAMA Cardiol. 2021 Feb 1;6(2):148-158
pubmed: 33031522
J Am Coll Cardiol. 2022 Mar 29;79(12):1129-1137
pubmed: 35331406
N Engl J Med. 2017 Aug 17;377(7):644-657
pubmed: 28605608
PLoS One. 2017 Feb 2;12(2):e0171106
pubmed: 28151999
Eur J Heart Fail. 2020 Apr;22(4):713-722
pubmed: 31912605
Front Cardiovasc Med. 2020 Dec 07;7:602251
pubmed: 33426003
N Engl J Med. 2019 Jun 13;380(24):2295-2306
pubmed: 30990260
Circulation. 2022 Jul 26;146(4):289-298
pubmed: 35766022
Diabetes Care. 2017 Oct;40(10):e141-e142
pubmed: 28765274
N Engl J Med. 2015 Nov 26;373(22):2117-28
pubmed: 26378978
Cardiovasc Diabetol. 2019 Feb 28;18(1):20
pubmed: 30819210
Kidney Int Rep. 2021 Dec 14;7(3):436-443
pubmed: 35257056
N Engl J Med. 2021 Jan 14;384(2):117-128
pubmed: 33200892
N Engl J Med. 2021 Oct 14;385(16):1451-1461
pubmed: 34449189
Kidney Int. 2018 Jan;93(1):231-244
pubmed: 28860019
N Engl J Med. 2020 Oct 8;383(15):1425-1435
pubmed: 32966714
N Engl J Med. 2019 Nov 21;381(21):1995-2008
pubmed: 31535829
Circulation. 2021 Jan 26;143(4):298-309
pubmed: 33040613
Lancet. 2022 Sep 3;400(10354):757-767
pubmed: 36041474
N Engl J Med. 2021 Jan 14;384(2):129-139
pubmed: 33200891
Circ Heart Fail. 2021 Mar;14(3):e007048
pubmed: 33663235
J Am Soc Nephrol. 2009 Feb;20(2):436-43
pubmed: 19092125
N Engl J Med. 2022 Sep 22;387(12):1089-1098
pubmed: 36027570
Kidney Int. 2013 Sep;84(3):622-3
pubmed: 23989362
N Engl J Med. 2013 Nov 14;369(20):1892-903
pubmed: 24206457
Kidney Int. 2014 Nov;86(5):1057-8
pubmed: 25360497
Lancet Diabetes Endocrinol. 2021 Jan;9(1):22-31
pubmed: 33338413
JACC Heart Fail. 2021 Apr;9(4):254-264
pubmed: 33549554
Ann Intern Med. 2001 Jul 17;135(2):73-87
pubmed: 11453706